Glaukos (GKOS) Research & Development (2014 - 2026)
Glaukos (GKOS) posted quarterly Research & Development of $51.3 million for Q2 2026, up 40.4% year-over-year from $36.5 million in Q2 2025, and up 16.21% quarter-over-quarter from $44.1 million in Q1 2026.
Glaukos (GKOS) Research & Development (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Research & Development for 13 consecutive years, with $51.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development rose 40.4% year-over-year to $51.3 million; the TTM figure through Jun 2026 stood at $177.2 million (up 26.4% YoY), while the FY2025 annual figure was $150.6 million, up 10.4% from the prior year.
- Research & Development climbed to $51.3 million in Q2 2026 per GKOS's latest filing, from $44.1 million in the prior quarter.
- Across five years, Research & Development topped out at $51.3 million in Q2 2026 and bottomed at $26.9 million in Q1 2022.
- Historically, Research & Development has averaged $35.8 million across 5 years, with a median of $35.0 million in 2023.
- Annual changes were most pronounced in 2024 — Research & Development retreated 12.64% — and 2026, when it surged 40.4%.
- Glaukos' Research & Development stood at $35.8 million in 2022, then grew by 3.49% to $37.1 million in 2023, then dropped by 1.44% to $36.5 million in 2024, then gained by 19.5% to $43.7 million in 2025, then gained by 17.53% to $51.3 million in 2026.
- Business Quant data shows GKOS's Research & Development at $51.3 million in Q2 2026, $44.1 million in Q1 2026, and $43.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Glaukos | 10.91 Bn | 10.80 Bn | 151.59 Mn | 51.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.30 Mn |
| Mar 31, 2026 | 44.15 Mn |
| Dec 31, 2025 | 43.65 Mn |
| Sep 30, 2025 | 38.07 Mn |
| Jun 30, 2025 | 36.54 Mn |
| Mar 31, 2025 | 32.35 Mn |
| Dec 31, 2024 | 36.53 Mn |
| Sep 30, 2024 | 34.75 Mn |
| Jun 30, 2024 | 34.43 Mn |
| Mar 31, 2024 | 30.73 Mn |
| Dec 31, 2023 | 37.06 Mn |
| Sep 30, 2023 | 33.30 Mn |
| Jun 30, 2023 | 33.23 Mn |
| Mar 31, 2023 | 35.17 Mn |
| Dec 31, 2022 | 35.81 Mn |
| Sep 30, 2022 | 28.87 Mn |
| Jun 30, 2022 | 31.71 Mn |
| Mar 31, 2022 | 26.88 Mn |
| Dec 31, 2021 | 26.68 Mn |
| Sep 30, 2021 | 28.85 Mn |